Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 7/2008

01.07.2008 | Inflammatory Disorders

Cyclosporin A in the ocular fluids of uveitis patients following long-term systemic administration

verfasst von: Paolo Mora, Uta Ceglarek, Francesca Manzotti, Laura Zavota, Arturo Carta, Raffaella Aldigeri, Jelka G. Orsoni

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 7/2008

Einloggen, um Zugang zu erhalten

Abstract

Background/aims

To determine the levels of cyclosporin A (CsA) in tears and the anterior segment of the eye following long-term oral intake for autoimmune diseases.

Methods

Subjects taking oral CsA to treat relapsing autoimmune ocular inflammation were included in this study. All of the patients had been quiescent for at least 6 months. In patients scheduled for cataract extraction (group A), the CsA levels in the blood, aqueous humour and anterior capsule of the lens were determined. In subjects not requiring surgical intervention (group B), CsA was measured in tears and blood. The samples were analysed using turbulent flow chromatography coupled with liquid chromatography-tandem mass spectrometry (LC-MS/MS).

Results

There were 19 subjects in group A and 43 subjects in group B. CsA was detectable in all of the tear samples with a mean value of 22.4 ± 20.2 ng/ml and there was a significant positive correlation between the CsA levels in tears and blood (P = 0.012). CsA was not detected in any of the surgical samples.

Conclusion

LC-MS/MS proved very sensitive for detecting CsA in low-volume biological samples. CsA was present in human tears in proportion to the blood level after an average of 12 hours from the last oral intake.
Literatur
1.
Zurück zum Zitat Noble S, Markham A (1995) Cyclosporin. A review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral). Drugs 50:924–941PubMedCrossRef Noble S, Markham A (1995) Cyclosporin. A review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral). Drugs 50:924–941PubMedCrossRef
2.
Zurück zum Zitat Ponticelli C (2005) Cyclosporine: from renal transplantation to autoimmune diseases. Ann NY Acad Sci 1051:551–558PubMedCrossRef Ponticelli C (2005) Cyclosporine: from renal transplantation to autoimmune diseases. Ann NY Acad Sci 1051:551–558PubMedCrossRef
3.
Zurück zum Zitat Nussenblatt RB, Palestine AG, Chan CC, Stevens GJ, Mellow SD, Green SB (1991) Randomized, double-masked study of cyclosporine compared to prednisolone in the treatment of endogenous uveitis. Am J Ophthalmol 112:138–146PubMed Nussenblatt RB, Palestine AG, Chan CC, Stevens GJ, Mellow SD, Green SB (1991) Randomized, double-masked study of cyclosporine compared to prednisolone in the treatment of endogenous uveitis. Am J Ophthalmol 112:138–146PubMed
4.
Zurück zum Zitat Masuda K, Nakajima A, Urayama A, Nakae K, Kogure M, Inaba G (1989) Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporine in Behcet’s disease. Lancet 1:1093–1096PubMedCrossRef Masuda K, Nakajima A, Urayama A, Nakae K, Kogure M, Inaba G (1989) Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporine in Behcet’s disease. Lancet 1:1093–1096PubMedCrossRef
5.
Zurück zum Zitat Lallemand F, Felt-Baeyens O, Besseghir K, Behar-Cohen F, Gurny R (2003) Cyclosporine A delivery to the eye: a pharmaceutical challenge. Eur J Pharm Biopharm 56:307–318PubMedCrossRef Lallemand F, Felt-Baeyens O, Besseghir K, Behar-Cohen F, Gurny R (2003) Cyclosporine A delivery to the eye: a pharmaceutical challenge. Eur J Pharm Biopharm 56:307–318PubMedCrossRef
6.
Zurück zum Zitat Benezra D, Maftzir G (1990) Ocular penetration of cyclosporine A. The rabbit eye. IOVS 31:1362–1366 Benezra D, Maftzir G (1990) Ocular penetration of cyclosporine A. The rabbit eye. IOVS 31:1362–1366
7.
Zurück zum Zitat Vernillet L, Lundh RL, Acetaz-Mispelter F, Goizel C, Humbert H, Pouliquen Y (1991) Ocular distribution of cyclosporine A (Sandimmun) following systemic and topical administration to rabbits. Eur J Drug Metab Pharmacokinet 3:150–158 Vernillet L, Lundh RL, Acetaz-Mispelter F, Goizel C, Humbert H, Pouliquen Y (1991) Ocular distribution of cyclosporine A (Sandimmun) following systemic and topical administration to rabbits. Eur J Drug Metab Pharmacokinet 3:150–158
8.
Zurück zum Zitat Oh C, Saville BA, Cheng YL, Rootman DS (1995) A compartmental model for the ocular pharmacokinetics of cyclosporine in rabbits. Pharm Res 12:433–437PubMedCrossRef Oh C, Saville BA, Cheng YL, Rootman DS (1995) A compartmental model for the ocular pharmacokinetics of cyclosporine in rabbits. Pharm Res 12:433–437PubMedCrossRef
9.
Zurück zum Zitat Benezra D, Maftzir G, De Courten C, Timonen P (1990) Ocular penetration of cyclosporine A. III: The human eye. Br J Ophthalmol 74:350–352PubMedCrossRef Benezra D, Maftzir G, De Courten C, Timonen P (1990) Ocular penetration of cyclosporine A. III: The human eye. Br J Ophthalmol 74:350–352PubMedCrossRef
10.
Zurück zum Zitat Palestine AG, Nussenblatt RB, Chan CC (1985) Cyclosporine penetration into the anterior chamber and cerebrospinal fluid. Am J Ophthalmol 99:210–211PubMed Palestine AG, Nussenblatt RB, Chan CC (1985) Cyclosporine penetration into the anterior chamber and cerebrospinal fluid. Am J Ophthalmol 99:210–211PubMed
11.
Zurück zum Zitat Tabbara KF, Gee SS, Alvarez H (1988) Ocular bioavailability of cyclosporine after oral administration. Transplant Proc 20(s2):656–659PubMed Tabbara KF, Gee SS, Alvarez H (1988) Ocular bioavailability of cyclosporine after oral administration. Transplant Proc 20(s2):656–659PubMed
12.
Zurück zum Zitat Althaus C, Dagres E, Reinhard T, Christians U, Sundemacher R (1996) Cyclosporin-A and its metabolites in the anterior chamber after topical and systemic application as determined with high-performance liquid chromatography-electrospray mass spectrometry. Ger J Ophthalmol 5:189–194PubMed Althaus C, Dagres E, Reinhard T, Christians U, Sundemacher R (1996) Cyclosporin-A and its metabolites in the anterior chamber after topical and systemic application as determined with high-performance liquid chromatography-electrospray mass spectrometry. Ger J Ophthalmol 5:189–194PubMed
13.
Zurück zum Zitat The Standardization of Uveitis Nomenclature (SUN) Working Group (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140:509–516CrossRef The Standardization of Uveitis Nomenclature (SUN) Working Group (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140:509–516CrossRef
14.
Zurück zum Zitat Ceglarek U, Lembcke J, Fiedler GM, Werner M, Witzigmann H, Hauss JP, Thiery J (2004) Rapid simultaneous quantification of immunosuppressants in transplant patients by turbulent flow chromatography combined with tandem mass spectrometry. Clin Chim Acta 346:181–190PubMedCrossRef Ceglarek U, Lembcke J, Fiedler GM, Werner M, Witzigmann H, Hauss JP, Thiery J (2004) Rapid simultaneous quantification of immunosuppressants in transplant patients by turbulent flow chromatography combined with tandem mass spectrometry. Clin Chim Acta 346:181–190PubMedCrossRef
15.
Zurück zum Zitat Dessars B, Cotton F, Thiry P, Gulbis B (2003) Comparison of automated ACMIA and EMIT immunoassays for whole blood cyclosporin monitoring. Clin Lab 49:135–140PubMed Dessars B, Cotton F, Thiry P, Gulbis B (2003) Comparison of automated ACMIA and EMIT immunoassays for whole blood cyclosporin monitoring. Clin Lab 49:135–140PubMed
16.
Zurück zum Zitat Bablok W, Passing H, Bender R, Schneider B (1988) A general regression procedure for method transformation. Application of linear regression procedures for method comparison studies in clinical chemistry, Part III. J Clin Chem Clin Biochem 26:783–790PubMed Bablok W, Passing H, Bender R, Schneider B (1988) A general regression procedure for method transformation. Application of linear regression procedures for method comparison studies in clinical chemistry, Part III. J Clin Chem Clin Biochem 26:783–790PubMed
17.
Zurück zum Zitat Theng J, Zhou L, Tan D, La KW (2002) Distribution of cyclosporine A in the cornea after topical or oral administration. J Ocul Pharmacol Ther 18:83–88PubMedCrossRef Theng J, Zhou L, Tan D, La KW (2002) Distribution of cyclosporine A in the cornea after topical or oral administration. J Ocul Pharmacol Ther 18:83–88PubMedCrossRef
Metadaten
Titel
Cyclosporin A in the ocular fluids of uveitis patients following long-term systemic administration
verfasst von
Paolo Mora
Uta Ceglarek
Francesca Manzotti
Laura Zavota
Arturo Carta
Raffaella Aldigeri
Jelka G. Orsoni
Publikationsdatum
01.07.2008
Verlag
Springer-Verlag
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 7/2008
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-008-0825-4

Weitere Artikel der Ausgabe 7/2008

Graefe's Archive for Clinical and Experimental Ophthalmology 7/2008 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Die überschießende Wundheilung in der filtrierenden Glaukomchirurgie ist ein zentraler Faktor für ein operatives Versagen. Nach der Einführung der Trabekulektomie in den 1960er-Jahren wurden viele Faktoren erkannt, die mit einer vermehrten …

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.